Fairmount Funds Management LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $294 Million distributed in 15 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Axsome Therapeutics, Inc. with a value of $95.1M, Nuvalent, Inc. with a value of $51.6M, Viridian Therapeutics, Inc.\De with a value of $46.4M, Scholar Rock Holding Corp with a value of $44.2M, and Cogent Biosciences, Inc. with a value of $37.3M.
Examining the 13F form we can see an decrease of $204M in the current position value, from $498M to 294M.
Fairmount Funds Management LLC is based out at Philadelphia, PA
Below you can find more details about Fairmount Funds Management LLC portfolio as well as his latest detailed transactions.
